Wed, Feb 27, 2019 - Page 7 News List

UK diabetics, firms hoard insulin in case of no deal


Diabetics and insulin providers in Britain are stockpiling the precious medicine to avoid potential shortages in case Britain leaves the EU without a deal in just more than a month.

“I started about two months ago,” said David Burns, a 37-year-old teacher living in London. “I used to pick up insulin once a month. Now I’m picking it up about once every two weeks and I am just going to keep doing this until I can be reassured that it is going to be OK.”

“But it’s likely we are heading for a no-deal Brexit and our country is in a very precarious position,” he added.

Many of Britain’s 3.7 million diabetics, who include British Prime Minister Theresa May, depend almost entirely on insulin imports from continental Europe.

The hormone, which is usually produced by the pancreas, helps diabetics regulate their blood sugar levels. A no-deal Brexit would almost certainly mean re-establishing customs and health controls, which could lead to delays at the border.

London and Brussels have said that they want to avoid this scenario, but nerves are fraying as the March 29 departure date looms.

“We definitely do hear that people are making sure that their stocks are a bit higher than usual,” Diabetes UK chief policy officer Robin Hewings told reporters.

Hewings played down fears of a “national shortage,” but warned that there could be localized issues.

Suppliers in Britain have tried to get ahead of the problem, exceeding the government’s recommendation to have enough inventory to last six weeks.

Novo Nordisk, which supplies more than half of the insulin used in Britain, has doubled its reserves.

“We will continue to build stock ahead of March 29, when we expect to have around two-and-a-half times our normal stock levels [about 17 weeks] in readiness for a potential no-deal Brexit,” the group said.

French group Sanofi, which produces insulin near Frankfurt, Germany, has also stocked up on drugs in Britain, including enough insulin to last 16 weeks.

US firm Eli Lilly, another insulin producer, said that it had “done everything in its power to prepare for Brexit,” but warned that “circumstances outside of our responsibility may disrupt medicines supply.”

“A no-deal Brexit would result in the UK’s complete and sudden disassociation from decades of partnership with the EU on medicines regulation and drug safety monitoring,” it added.

Diabetes UK and nonprofit JDRF have called on the government to provide more details on its preparations in case of a no-deal Brexit.

They said that in addition to insulin, people with diabetes use other drugs and imported products such as needles, insulin pumps and devices used to measure blood glucose levels.

The British Department of Health and Social Care has sought to reassure those affected and has welcomed the efforts of the pharmaceutical industry.

“We are confident that, if everyone does what they should do, the supply of medicines will be uninterrupted in the event of a no-deal,” a department spokesman told reporters.

The department’s plans include fast-track emergency medicine deliveries by sea and air in case of congestion at the border.

However, not all patients have been comforted by the government’s words.

“If I don’t have insulin, then I would go immediately to hospital because, you know, I could be sick in a matter of days and dead in a matter of weeks,” Burns said. “This is not something I want to test.”

This story has been viewed 2218 times.

Comments will be moderated. Keep comments relevant to the article. Remarks containing abusive and obscene language, personal attacks of any kind or promotion will be removed and the user banned. Final decision will be at the discretion of the Taipei Times.

TOP top